FDA doesn’t Recommend Using Ovarian Cancer Screening TestsCreated by:
In a new update, The FDA is warning women about the possible risks with using tests being marketed as ovarian cancer screening tests. The Agency is especially concerned about women who are still at increased risk for developing ovarian cancer although they show no symptoms; leading to delaying necessary preventive measures due to the low sensitivity of these tests.
"These women and their doctors may not take appropriate actions to reduce their future risk if they rely on a result that shows no cancer currently present," the FDA stated. "Yet, this group of women is still at high risk of developing ovarian cancer later based on their gene mutation and/or family history. The FDA believes that women at high risk for developing ovarian cancer should not use any currently offered test that claims to screen for ovarian cancer." especially because the false negative results they may provide.
The agency advises clinicians to not recommend any of these tests to women and tp refer such high-risk women to a genetic counselor, a gynecologic oncologist, or some other appropriate specialist.
The agency also urges women to be ware there is currently no safe and effective ovarian cancer screening test and these tests are not reliable to take decisions based on their results. Instead, the FDA encourages women to talk to their doctors about ways to reduce the risk of developing ovarian cancer, especially if they have a family history of ovarian cancer, or have the BRCA1 or BRCA2 genetic mutations.